Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02049320

Enrollment

Registered

2014-01-30

Start date

2013-07-31

Completion date

2016-05-31

Last updated

2017-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Brief summary

This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.

Interventions

DRUGRemifentanil

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients previously admitted to the hospital presenting with traumatic brain injury (TBI) * Patients who have undergone sedation after presenting with TBI

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Depth of Sedation	Every 24 hrs until discharged from the PICU, up to 1 month.	Sedation scores will be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026